L'intérêt à découvert pour ECARX Holdings donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de ECARX Holdings. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

ECARX Holdings (NASDAQ:ECX) Stock, Rapport sur les intérêts à découvert

ECARX Holdings

ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services primarily in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.

ECARX Holdings Inc. - Class A Ordinary shares

ECARX Holdings Inc

CXJ Group Co Ltd

FLEETPARTNERS GRP LTD by FLEETPARTNERS GROUP LTD.

FleetPartners Group Ltd

<a href="https://www.benzinga.com/personal-finance/25/02/43885487/billionaire-mark-cuban-said-the-first-step-to-getting-rich-is-giving-things-up-drink-water-eat-mac-and-cheese-and-save-every-penny">Billionaire Mark Cuban</a> isn't just talking about taxes—he's paying them. Last year, he wired $275.9 million to the IRS, and he's not complaining about it.&nbsp;
Last week, when someone on <a href="https://bsky.app/profile/mcuban.bsky.social/post/3ljbuhz3jz22u">BlueSky</a> asked, "Can't we just TAX billionaires a little bit MORE instead of firing the people controlling our nuclear weapons and fighting pandemics?" Cuban had a simple answer: "Yes."
That's it. No hedging, no dodging. Just a straightforward agreement that, instead of gutting government jobs, maybe billionaires should be taxed a little more. And considering his tax bill was larger than what thousands of Americans combined will earn in their entire lifetimes, he's not just talking—he's putting his money where his mouth is.
Don't Miss:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li><a href="https://www.benzinga.com/money/millionaires-never-earned-six-figures-according-to-dave-ramsey">69% of Millionaires Never Earned A Six-Figure Salary – Here Are 2 Things They Do To Get Their First $1 Million, According To Dave Ramsey</a></li>
</ul>
<h2 class="wp-block-heading">Cuban's Take: Billionaires Can Afford It</h2>
Cuban made it clear last year that he has no issue paying what he owes.
"I pay what I owe. This country has done so much for me, I'm proud to pay my taxes every single year," <a href="https://x.com/mcuban/status/1779905354601484638">he wrote on X</a> back in April.
And he didn't just say it—he backed it up. The $275.9 million he paid was mostly from long-term capital gains, likely tied to his <a href="https://www.benzinga.com/startups/24/08/40463542/mark-cuban-sold-his-nba-team-because-the-next-wave-of-revenue-generation-is-around-real-estate-and-a">$3.5 billion sale of the NBA's Dallas Mavericks</a>. But rather than using that as an excuse to advocate for tax cuts or loopholes, Cuban sees it as part of the deal.
"We only get to be entrepreneurs and enjoy the freedoms we have because of the men and women who dedicate their lives to protecting our country. They deserve every penny they get, and my taxes go to support them," he <a href="https://www.cnbc.com/2024/04/15/how-much-mark-cuban-pays-in-taxes.html">told CNBC</a>.
Trending: How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.
<h2 class="wp-block-heading">Government Layoffs Instead of Tax Hikes</h2>
Cuban's BlueSky post came in response to widespread government job cuts happening under the Trump administration's Department of Government Efficiency—an initiative linked to Elon Musk. DOGE has been aggressively slashing federal jobs, with estimates suggesting up to 700,000 positions could be eliminated.
The reasoning? Budget cuts. The result? Government agencies are scrambling to operate with fewer employees, even in crucial areas like public safety and health.
<h2 class="wp-block-heading">Buffett's Billion-Dollar Perspective</h2>
Cuban isn't alone in this thinking. Warren Buffett has been saying for years that billionaires and corporations should be paying more. His company, Berkshire Hathaway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>, BRK.B)), paid a <a href="https://www.benzinga.com/news/25/02/44049686/warren-buffetts-subtle-message-to-trump-spend-it-wisely-after-berkshires-record-26-8-billion-tax-payment">record $26.8 billion in taxes</a>—the largest corporate tax bill in U.S. history.
See Also: <a href="https://www.benzinga.com/money/mark-cubans-advice-for-lotto-winners">Many are surprised by Mark Cuban's advice for lotto winners: Cash or annuity?</a>
Buffett even suggested at the 2024 Berkshire Hathaway Annual Meeting that if just 800 other companies paid the same amount in federal taxes, the entire country's tax burden would disappear:
"No other person in the United States would have had to <a href="https://www.benzinga.com/personal-finance/25/02/43975331/warren-buffett-paid-5-billion-in-taxes-and-says-if-800-other-companies-paid-their-share-no-one-else-would-have-to-pay-a-dime">pay a dime of federal taxes</a>—no income taxes, no Social Security taxes, no estate taxes."
<h2 class="wp-block-heading">Who Should Shoulder the Burden?</h2>
Cuban isn't saying billionaires should be taxed into oblivion. He's just saying there's a better way to balance the budget than firing thousands of workers. He's leading by example—paying his fair share without complaints and openly advocating for a tax system that makes sense.
With Buffett echoing similar sentiments, the question isn't whether billionaires can afford it—it's whether lawmakers will actually make them.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/money/suze-orman-retirement-bucket">&#8216;Which Bucket Do I Draw From First?&#8217; Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts</a></li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>

Personal Finance

Mark Cuban Was 'Proud' To Pay His $275.9M Tax Bill Last Year — And Says 'Yes' To Taxing Billionaires More Instead Of Slashing Jobs

Barrington Research analyst Alexander Paris maintains SuRo Capital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSSS#NASDAQ">SSSS</a>) with a Outperform and maintains $8 price target.

News

Price Target

Analyst Ratings

SSSS

Barrington Research Maintains Outperform on SuRo Capital, Maintains $8 Price Target

Barrington Research analyst Vincent Colicchio maintains Climb Global Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLMB#NASDAQ">CLMB</a>) with a Outperform and maintains $136 price target.

CLMB

Barrington Research Maintains Outperform on Climb Global Solutions, Maintains $136 Price Target

Wells Fargo analyst Eva Fortea Verdejo maintains ITeos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITOS#NASDAQ">ITOS</a>) with a Overweight and lowers the price target from $19 to $17.

ITOS

Wells Fargo Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $17

UBS analyst Trung Huynh maintains Insmed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INSM#NASDAQ">INSM</a>) with a Buy and raises the price target from $105 to $110.

INSM

UBS Maintains Buy on Insmed, Raises Price Target to $110

UBS analyst Roger Boyd maintains Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) with a Buy and raises the price target from $250 to $260.

UBS Maintains Buy on Zscaler, Raises Price Target to $260

Walgreens Boots Alliance Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) shares are trading higher in Thursday&#8217;s after-hours session after the company announced a deal to be <a href="https://in.benzinga.com/general/market-summary/25/03/44102644/walgreens-could-go-private-this-week-after-a-10-billion-deal-with-sycamore-partners-report">acquired by Sycamore Partners</a>.
What Happened: After the market close on Thursday, Walgreens announced it entered into a definitive agreement to be taken private by an entity affiliated with Sycamore Partners for $10 billion.
Walgreens shareholders will receive $11.45 per share in cash at closing. Shareholders are also eligible to receive up to $3 in cash per share from the future monetization of Walgreens&#8217; debt and equity interests in VillageMD, which includes the Village Medical, Summit Health and CityMD businesses.
&#8220;While we are making progress against our ambitious turnaround strategy, meaningful value creation will take time, focus and change that is better managed as a private company. Sycamore will provide us with the expertise and experience of a partner with a strong track record of successful retail turnarounds,&#8221; said Tim Wentworth, CEO of Walgreens.
&#8220;The WBA Board considered all these factors in evaluating this transaction, and we believe this agreement provides shareholders premium cash value, with the ability to benefit from additional value creation going forward from monetization of the VillageMD businesses.&#8221;
See Also: <a href="https://www.benzinga.com/news/earnings/25/03/44181200/broadcom-stock-surges-on-q1-earnings-beat-revenue-beat-strong-guidance-we-expect-continued-strength-in-ai-semiconductor-revenue">Broadcom Stock Surges On Q1 Earnings Beat, Revenue Beat, Strong Guidance: &#8216;We Expect Continued Strength In AI Semiconductor Revenue&#8217;</a>
Walgreens&#8217; board unanimously approved the proposed transaction, which is expected to close in the fourth quarter of 2025. Upon completion of the transaction, Walgreens will become a private company and the company&#8217;s common stock will be delisted from the Nasdaq.
Walgreens noted it will release its <a href="https://www.benzinga.com/calendars/earnings">second-quarter financial results</a> on April 8. Analysts currently expect the company to report earnings of 52 cents per share and revenue of $38.04 billion, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>.
WBA Price Action: <a href="http://benzinga.com/quote/wba">Walgreens shares</a> were up 5.85% after hours, trading at $11.22 at the time of publication Thursday, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Courtesy of Walgreens Boots Alliance.

After-Hours Center

Movers

Walgreens Stock Rises As Company Inks $10B Deal To Go Private

Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) has outperformed the market over the past 20 years by 5.67% on an annualized basis producing an average annual return of 13.79%. Currently, Gilead Sciences has a market capitalization of $144.34 billion. 
Buying $100 In GILD: If an investor had bought $100 of GILD stock 20 years ago, it would be worth $1,300.17 today based on a price of $115.90 for GILD at the time of writing.
<h3>Gilead Sciences's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1741302909_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

GILD

Here's How Much You Would Have Made Owning Gilead Sciences Stock In The Last 20 Years

Retirement planning isn't exactly the most exciting topic. Until you realize you can actually get free money for investing in your future. <a href="https://www.benzinga.com/money/robinhood-review">Robinhood</a> is flipping the script on IRAs with an offer that's hard to ignore. Earn 3% extra on annual contributions when you <a href="https://www.benzinga.com/go/robinhood-gold-credit-card">subscribe to Robinhood Gold</a>, plus an uncapped 2% boost on transfers and rollovers until April 30. 
<ul>
<li><a href="https://www.benzinga.com/go/robinhood-retirement">Sign up for a Robinhood Retirement account now</a></li>
</ul>
<h2 class="wp-block-heading">Why Settle for Ordinary When You Can Boost Your IRA?</h2>
You work hard for your money, so why not make it work harder for you? With <a href="https://www.benzinga.com/go/robinhood-retirement">Robinhood's IRA</a>, every contribution gets an instant 3% boost when you&#8217;re a Robinhood Gold subscriber. And if you're rolling over funds from another retirement account, you'll get a 2% boost. No cap, no gimmicks, just extra cash added to your investments.
If you're serious about maxing out your IRA for 2025, there's another sweet deal: contribute the full amount by April 15, 2025, and you could snag an extra $420 in matching funds.
<h2 class="wp-block-heading">The Robinhood IRA Advantage</h2>
This isn't just another IRA. Robinhood is rewriting the rules with a platform built for simplicity, flexibility, and more money in your pocket.
<h3 class="wp-block-heading">Tax Advantages That Keep More Money in Your Pocket</h3>
Your <a href="https://www.benzinga.com/money/how-to-invest-your-ira">earnings in an IRA</a> grow tax-deferred or tax-free, depending on whether you choose a Traditional or Roth IRA. That means more of your money stays invested, compounding over time instead of going to the <a href="https://www.irs.gov/">IRS</a>.
<h3 class="wp-block-heading">Options Trading in a Tax-Advantaged Account</h3>
Not ready to retire from active investing? Robinhood lets qualified traders trade options on stocks and ETFs inside their IRA, with no commission or per-contract fees. That means you get the flexibility of options trading without the tax hit you'd face in a traditional brokerage account.
<h3 class="wp-block-heading">Already Have a 401(k)? Stack an IRA on Top</h3>
A 401(k) is great, but it might not be enough. If you're already maxing out your employer-sponsored plan, you can still contribute up to $7,000 in an IRA for 2025. More investment, more tax advantages, and with Robinhood, more free money with every contribution.
<h3 class="wp-block-heading">One Platform for Everything</h3>
Tired of tracking retirement accounts across different platforms? Robinhood makes it easy to find and consolidate your retirement savings in one place. Whether you&#8217;re rolling over an old 401(k) or moving funds from another IRA, the process is simple, fast, and now comes with a 2% cash boost on all transfers.
<h2 class="wp-block-heading">Who Should Consider a Robinhood IRA?</h2>
<ul>
<li>Investors who want more money upfront. Get an instant 3% boost on contributions</li>
<li>People who already <a href="https://www.benzinga.com/money/how-to-invest-your-401k">max out a 401(k)</a>. Stack an IRA on top for even greater tax benefits</li>
<li>Anyone looking for low-cost, commission-free investing. No hidden fees or per-contract costs</li>
<li>Self-employed workers or freelancers. No employer 401(k)? No problem. Robinhood's IRA puts you in control</li>
<li>Long-term investors who want to grow wealth tax-efficiently. Keep more of your gains over time</li>
</ul>
<h2 class="wp-block-heading">The Clock is Ticking</h2>
This isn't a forever deal. That 2% unlimited transfer boost disappears after April 30, and the $420 max-out match is only available if you contribute by April 15, 2025. The 3% instant match is here to stay for Robinhood Gold subscribers, but why wait? The sooner you contribute, the more time your money has to grow.
<ul>
<li><a href="https://www.benzinga.com/go/robinhood-retirement">Sign up for a Robinhood Retirement account now</a></li>
</ul>
Over 1,000,000 people have trusted Benzinga to help them choose their investing tools. Our experts are hard at work with constant updates as products &amp; markets change! Benzinga is a reader-supported publication. We may earn a commission from the advertisers associated with this article. This article is not sponsored.

Robinhood's Retirement Account Just Got Even More Interesting

Maxim Group analyst Matthew Galinko downgrades Arbe Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBE#NASDAQ">ARBE</a>) from Buy to Hold.

Downgrades

ARBE

Maxim Group Downgrades Arbe Robotics to Hold

Lake Street analyst Frank Takkinen maintains Sight Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGHT#NASDAQ">SGHT</a>) with a Hold and lowers the price target from $3 to $2.5.

SGHT

Lake Street Maintains Hold on Sight Sciences, Lowers Price Target to $2.5

Lake Street analyst Jacob Stephan maintains CompoSecure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPO#NASDAQ">CMPO</a>) with a Buy and lowers the price target from $18 to $15.

CMPO

Lake Street Maintains Buy on CompoSecure, Lowers Price Target to $15

Lake Street analyst Jaeson Schmidt maintains Identiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVE#NASDAQ">INVE</a>) with a Buy and lowers the price target from $7 to $6.

INVE

Lake Street Maintains Buy on Identiv, Lowers Price Target to $6

The Ordinary Shares are expected to begin trading on the NYSE American under the ticker symbol "MCRP" on March 7, 2025. The Offering is expected to close on March 10, 2025, subject to satisfaction of customary closing conditions.

IPOs

MCRP

Micropolis Prices IPO Of 3.875M Ordinary Shares At $4.00 Per Share; To Begin Trading On NYSE American Under Ticker Symbol 'MCRP' On March 7

Jefferies analyst Anthony Petrone maintains Tarsus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARS#NASDAQ">TARS</a>) with a Buy and raises the price target from $54 to $58.

TARS

Jefferies Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $58

The CFPB's dismissal follows its multi-year investigation which began prior to Upbound's acquisition of Acima in 2021. Acima will not pay any money, be required to change any business practices, or be subject to any injunctive or other relief, and the dismissal with prejudice ends the CFPB's challenge to the alleged business practices that were the subject of its investigation and lawsuit.
In connection with the CFPB's determination to drop its claims against Acima, Acima has agreed to dismiss the lawsuit it filed against the CFPB in the United States District Court for the Eastern District of Texas, which challenged the CFPB's authority to pursue those claims against Acima.

Legal

UPBD

Upbound Says Consumer Financial Protection Bureau Has Voluntarily Dismissed Lawsuit Against Its Unit Acima Leasing

Jones Trading analyst Matthew Erdner maintains Real Brokerage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REAX#NASDAQ">REAX</a>) with a Buy and maintains $6 price target.

REAX

Jones Trading Maintains Buy on Real Brokerage, Maintains $6 Price Target

Scotiabank analyst Patrick Colville maintains Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) with a Sector Outperform and raises the price target from $225 to $242.

Scotiabank Maintains Sector Outperform on Zscaler, Raises Price Target to $242

DXP Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXPE#NASDAQ">DXPE</a>) reported quarterly earnings of $1.38 per share which beat the analyst consensus estimate of $0.89 by 55.06 percent. This is a 23.21 percent increase over earnings of $1.12 per share from the same period last year. The company reported quarterly sales of $470.91 million which beat the analyst consensus estimate of $447.00 million by 5.35 percent. This is a 15.69 percent increase over sales of $407.04 million the same period last year.

Earnings

Earnings Beats

DXPE

DXP Enterprises Q4 2024 Adj EPS $1.38 Beats $0.89 Estimate, Sales $470.91M Beat $447.00M Estimate

Trading Halt: Halt status updated at 5:40:00 PM ET: Quotation Resumption: News and Resumption Times

Press Releases

ECARX Receives SASO Award for Contributions to Generative AI Quality Assurance at Saudi Arabia's National Quality Conference

General

ECARX Announces US$20,000,000 Share Repurchase Program

ECARX's Cloudpeak® Hypervisor Receives ISO 26262 ASIL-D Certification

Management

ECARX Announces Board Change

ECARX AutoGPT Integrates DeepSeek-R1 Model

ECARX to Power Launch of First Hongqi Model Under Strategic Partnership with FAW, Debuting AutoGPT with DeepSeek-R1 Integration

ECARX to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

ECARX Solutions Contribute to Geely's Record-Breaking Sales in January 2025, Showcasing Scalable, Cost-Effective Solutions

ECARX Integrates DriveDreamer World Model into AutoGPT

ECARX to provide Volkswagen Brazil and Skoda with digital cockpit solutions

Adient

Autoliv

American Axle & Manufacturing Holdings, Inc. Common Stock

American Axle & Mfg Hldgs

BorgWarner

Cooper-Standard Holdings Inc. Common Stock

Cooper-Standard Holdings

Dana

Dorman Products

Fox Factory Holding

Gentex

Garrett Motion

Holley

Hesai Group - American Depositary Share, each ADS represents one Class B ordinary share

Hesai Gr

LCI Industries

Lear

Mobileye Global Inc. - Class A Common Stock

Mobileye Global

Modine Manufacturing Company Common Stock

Modine Manufacturing

Patrick Industries

Phinia

QuantumScape Corporation Class A Common Stock

QuantumScape

Solid Power

Standard Motor Products, Inc. Common Stock

Comments

ECARX Holdings

Intérêt court

ECARX Holdings (NASDAQ:ECX) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL